Study: SPECT to remain steady, PET-CT will surge in Europe

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The introduction of new technologies is set to revitalize the increasingly mature European nuclear medical imaging markets, according to a study released today by Frost & Sullivan titled ”Nuclear Medicine Imaging Systems Markets in Europe.” Despite relative stability, innovative and enhanced imaging techniques such as SPECT will energize the saturated gamma camera segment. PET-CT scanners will rapidly replace existing PET systems, resulting in revenue attenuation, the study said.
   
Frost & Sullivan finds that the European nuclear medicine imaging systems markets earned revenues of $155.7 million in 2005 and estimates to reach $138.9 million in 2010.

Molecular imaging is now considered the technology of the future as it provides detailed information about diseases and methods to treat them, the study noted. This will promote the uptake of advanced technologies in nuclear medicine imaging.

Saturation in the gamma market can be overcome only through the introduction of new applications. In the case of the PET scanners market, the availability of its radioisotopes will generate additional interest among end users.

To sustain their profitability, market vendors need to design appropriate pricing plans for their systems and create more awareness on the advantages of new technologies and applications. Also, an adequate focus on partnering with radiopharmaceuticals companies will help market participants offer comprehensive solutions to customers.